Pharma law

• Consultation on claw-back legislation;
• Authorization requests at the National Agency of the medicinal product;
• Appeals to clients at the National Health Insurance House regarding issues regarding the calculation of the claw-back contribution (including the filing of complaints against house notifications in this field);
• Competition law, sanctions on the investigation conducted by the Competition Council – Representation in the investigations, contesting the sanctions in the instant;